ALEMBIC PHARMACEUTICALS LTD. - 533573 - Proceedings Of The 9Th Annual General Meeting Held On 29Th July, 2019
In accordance with the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith proceedings of the 9th Annual General Meeting of the Company held on 29th July, 2019. We request you to kindly take the same on record. Alembic Pharma Q1 net profit rises 37% to Rs 124 cr
Alembic Pharmaceuticals on Monday posted a 36.75 per cent rise in its consolidated net profit to Rs 123.72 crore for the first quarter ended June 30, ALEMBIC PHARMACEUTICALS LTD. - 533573 - Consolidated And Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2019.
With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter ended on 30th June, 2019. We enclose herewith the following: a) Consolidated Unaudited Financial Results for the quarter ended on 30th June, 2019. b) Standalone Unaudited Financial Results for the quarter ended on 30th June, 2019. c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results. d) Press Release. e) Investor Presentation. The time of commencement of the Board Meeting was 11:30 a.m. and the time of conclusion was 2:15 p.m. We request you to kindly take the same on record. Alembic Pharmaceuticals Ltd - 533573 - Outcome of Board Meeting
With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter ended on 30th June, 2019. We enclose herewith the following: a) Consolidated Unaudited Financial Results for the quarter ended on 30th June, 2019. b) Standalone Unaudited Financial Results for the quarter ended on 30th June, 2019. c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results. d) Press Release. e) Investor Presentation. The time of commencement of the Board Meeting was 11:30 a.m. and the time of conclusion was 2:15 p.m. We request you to kindly take the same on record. Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Tentative Approval for Dapagliflozin Tablets, 5 mg and 10 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record. Alembic Pharma gets USFDA nod for neuropathic pain management drug
Drug firm Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator for Pregabalin Capsules, indicated for manage Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Shareholding for the Period Ended June 30, 2019
Alembic Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of advertisement related to notice of loss of share certificates published by the Company on behalf of the shareholder(s) and / or legal heir(s) of the registered shareholder(s) in English language newspaper - Business Standard on 19th July, 2019. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of Notice of Board Meeting published in English and vernacular language (Gujarati) newspaper on 19th July, 2019 in Economic Times English and Gujarati Edition.